APP Seminar Series
Thank you to Dr. Bramham and Dr. Plemel for presenting recently for the APP Seminar Series.
New Cayabyab Lab Publication
New Cayabyab lab publication in Molecular Neurobiology describes novel mechanisms in delayed neuronal death in stroke-like conditions. A clinically relevant drug called Perampanel (used for treatment-resistant epilepsy) proved to be neuroprotective, prompting subsequent in vivo drug efficacy studies with promising results in animal stroke model. This study provides greater rationale for further drug development targeting the adenosinergic and glutamatergic signaling for future neuroprotective therapy for stroke patients. Open Access of the article through link: https://link.springer.com/article/10.1007/s12035-020-02246-0
Furber Lab looking for trainee
PDF, PhD or MSc positions available in the research group of Dr. Kendra Furber to study neural development and aging at the University of Norther British Columbia